R. Erik Holmlin - 15 Feb 2023 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: President and CEO, Director
Signature: /s/ R. Erik Holmlin
Issuer symbol: BNGO
Transactions as of: 15 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2023, 18:23:47 UTC
Previous filing: 16 May 2022
Next filing: 16 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Award	$0	+300,000	+55%	$0.000000	841,615	15 Feb 2023	Direct	F1, F2
holding	BNGO	Common Stock						5,025	15 Feb 2023	Robert Erik Holmlin Traditional IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+1,400,000		$0.000000	1,400,000	15 Feb 2023	Common Stock	1,400,000	$1.63	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
F2	Includes 1,443 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 1,616 shares acquired under the ESPP on December 10, 2022.
F3	The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.